Evogene Ltd (EVGN) – aksjekurser og nyheter

Symboler Symboler	Pris	Endring	Endring (%)	Trend	Forrige pris ved stengetid	Åpne	Høy	Lav	Volum	Markedsverdi
SIXB Materials SIXB Materials	SIXB −1,41%	1 076,13	−15,38	−1,41%	—	1 091,51	1 090,40	1 090,40	1 073,69	—	—
SIXC Communications SIXC Communications	SIXC −0,55%	606,74	−3,37	−0,55%	—	610,11	610,11	610,29	606,17	—	—
SIXE Energy SIXE Energy	SIXE +0,88%	1 248,82	+10,84	+0,88%	—	1 237,98	1 237,83	1 252,41	1 225,03	—	—
SIXI Industrials SIXI Industrials	SIXI −1,17%	1 724,36	−20,35	−1,17%	—	1 744,71	1 740,95	1 747,29	1 721,57	—	—
SIXM Financials SIXM Financials	SIXM −0,72%	635,59	−4,59	−0,72%	—	640,18	639,92	643,19	634,73	—	—
SIXR Staples SIXR Staples	SIXR −0,76%	843,15	−6,43	−0,76%	—	849,58	845,27	851,68	839,47	—	—
SIXRE Real estate SIXRE Real estate	SIXRE −0,55%	216,29	−1,19	−0,55%	—	217,48	217,48	218,16	215,51	—	—
SIXT Technology SIXT Technology	SIXT +0,08%	3 263,41	+2,72	+0,08%	—	3 260,69	3 273,36	3 287,81	3 240,78	—	—
SIXU Utilities SIXU Utilities	SIXU −0,34%	939,24	−3,21	−0,34%	—	942,45	939,39	948,80	933,98	—	—
SIXV Health care SIXV Health care	SIXV −0,29%	1 462,56	−4,24	−0,29%	—	1 466,80	1 464,70	1 467,19	1 458,36	—	—
SIXY Discretionary SIXY Discretionary	SIXY −0,71%	2 380,40	−17,10	−0,71%	—	2 397,50	2 395,03	2 412,01	2 370,64	—	—

EVGN:NASDAQ

Evogene Ltd

0,75 USD

−1,83%

(−0,014) 1 D

4. mai, 16:00:01 GMT-4 · USD

Alle symboler

1 D

5 D

1 M

6 M

I år

1 Å

5 Å

MAKS

	Symbol	Pris	Endring	Endring (%)

Genererer viktig statistikk for EVGN …

Åpne

0,76 USD

Høy

0,80 USD

Lav

0,74 USD

Markedsverdi

6,55 mill.

Snittvolum

88,30k

Volum

43,10k

52 u høy

2,42 USD

52 u lav

0,72 USD

EPS

−1,80 USD

Beta

1,39

Utestående aksjer

9,89 mill.

Antall ansatte

Relaterte aksjer

X T L Biopharmaceuticals Ltd

Nyhetssaker

Fra kilder på nettet

Newser

for 2 uker siden

EVGN (Evogene Ltd Ordinary Shares) posts far wider Q4 2025 per share loss than analyst estimates amid ongoing operational headwinds. - Verified Stock Signals

Newser

for 2 uker siden

Evogene (EVGN) Stock: Breakout Signals (Underperforming) 2026-04-16 - Value Investing

Profil

Evogene is a computational chemistry company based in Israel, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters. This powerful platform significantly improves success rates while reducing development time and costs. Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products driven by the integration of scientific innovation with real-world industry needs. In 2024, the company began collaborating with Google Cloud to develop an AI-powered generative model aimed at discovering small molecules for drug development and sustainable agriculture. Wikipedia

Om Evogene Ltd

Administrerende direktørOfer Haviv

Ansatte52

Grunnlagt1999

Hovedkontor-

Sektor-

Nettstedevogene.com

Alle verdier i USD	mars 2025	juni 2025	sep. 2025	des. 2025
Inntekt	2,44 mill.	884,00k	312,00k	314,00k
Varekostnad	1,61 mill.	136,00k	157,00k	2,28 mill.
Direkte driftskostnader	1,61 mill.	136,00k	157,00k	2,28 mill.
Utgifter til forskning og utvikling	3,21 mill.	2,32 mill.	1,38 mill.	1,83 mill.
Totale kostnader til forskning og utvikling	-	-	-	-
Salgskostnader, generelle kostnader og administrative kostnader	1,94 mill.	1,50 mill.	1,50 mill.	1,20 mill.
Driftskostnader	4,96 mill.	3,82 mill.	2,88 mill.	3,00 mill.
Totale driftskostnader	6,57 mill.	3,96 mill.	3,04 mill.	5,28 mill.
Driftsinntekter	−4,13 mill.	−3,07 mill.	−2,72 mill.	−4,97 mill.
Andre ikke-operasjonelle inntekter	-	-	-	668,00k
EBT inkludert uvanlige elementer	−2,99 mill.	−4,68 mill.	−2,73 mill.	−5,34 mill.
EBT uten uvanlige elementer	−2,99 mill.	−3,53 mill.	−2,73 mill.	−5,09 mill.
Kostnad for inntektsskatt	-	1,00k	1,00k	-
Faktisk avgiftssats	-	−0,02 %	−0,04 %	-
Andre driftskostnader	−191,00k	-	9,00k	−27,00k
Nettoinntekt	−2,59 mill.	−4,46 mill.	3,87 mill.	−5,31 mill.
Netto fortjenestemargin	−105,85 %	−504,75 %	1 241,67 %	−1 690,76 %
Resultat per aksje	−0,38	−0,50	−0,46	−0,62
Rente- og investeringsinntekter	1,60 mill.	235,00k	465,00k	1,38 mill.
Rentekostnader	−464,00k	−628,00k	−453,00k	−1,93 mill.
Netto rentekostnader	1,14 mill.	−393,00k	12,00k	−545,00k
Avskrivnings- og amortiseringskostnader	-	-	-	-
EBITDA	−3,55 mill.	−2,78 mill.	−2,44 mill.	−4,70 mill.
Gevinst eller tap ved salg av eiendeler	-	−3,00k	12,00k	−27,00k

AI-innhold kan inneholde feil. Finn ut mer

HjelpSend tilbakemeldingPersonvern Vilkår Ansvarsfraskrivelse

Finance

Utforskning